FutureCeuticals (Momence, IL) announced the publication of a second study assessing the effects of Spectra, a blend of 30 fruit, vegetable and herbal powders and extracts that have been scientifically balanced to deliver targeted antioxidant potential.
"This study confirms that Spectra is truly unique to the market," said John Hunter, senior advisor, FutureCeuticals. "Although the research community has generally agreed that maintenance of healthy levels of free radicals and related oxidants are important for good health, the problem to date has been that no one has been able to connect the ingestion of any antioxidant-type product with actual in vivo changes in free radical concentrations."
The advisor said Spectra's research team has further indicated interesting responses in humans in the area of inhibition of reactive oxygen species (ROS) and with up-regulation of no concentrations. "This is extremely exciting. To the best of our knowledge, this is the first time that any dietary supplement has been shown to be able to modulate ROS in real time in a clinical setting," he said.
Dr. Boris Nemzer, director of Research, Development and Quality Assurance, said FutureCeuticals has measured the biological effects of a natural supplement on changes in Oxidative Stress Markers (OSM) and cellular metabolic activity in the human body.
"The unique design and activity of this 100 percent plant-based natural supplement, in combination with the newly-developed and validated testing methodology, demonstrates a new potential for using clinically tested dietary supplements to modulate OSM, and also opens the door to future research into the use of natural supplements to support optimal health," said Nemzer."
The published study is available at: http://onlinelibrary.wiley.com/doi/10.1002/fsn3.178/full